However, CRC-bearing rats treated with PGPs or their nanoemulsion formulation at 200 mg/kg body weight for 12 weeks showed a significant decline (P < 0.05) in IL-6 levels compared to untreated rats, indicating their potent anti-inflammatory effect. This evidence concerns the gene IL6 and colorectal carcinoma.